Eurican L4 Suspension for Injection

• Target species: Dogs
• Active substances: Leptospira interrogans serogroup Australis, Leptospira interrogans serogroup Canicola, Leptospira interrogans serogroup Grippotyphosa, Leptospira interrogans serogroup Icterohaemorrhagiae
• Pharmaceutical form: Suspension for injection
• Therapeutic group: Inactivated Bacterial Vaccine
• Authorisation route: National
• Legal category: POM-V
• Controlled drug status: Not a controlled drug
• Marketing Authorisation holder: Boehringer Ingelheim Vetmedica GmbH
• Distributors: <span>Boehringer Ingelheim Vetmedica GmbH</span>
• Territory: Great Britain
• SPC: https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2572039.PDF
• UKPAR: https://www.vmd.defra.gov.uk/productinformationdatabase/files/UKPAR_Documents/UKPAR_2611835.PDF